Small scale CRO MVG serves small to mid-sized biotech and pharma companies, presenting an opportunity to position them as an affordable, flexible alternative to large CROs for clinical development programs.

End-to-end Teams They offer comprehensive project teams including start-up and virtual company support, suggesting upsell potential for full-service staffing on short and long-term projects across clinical quality assurance, operations, project management and medical writing.

Established track With a long-standing presence since 1998, MVG can leverage credibility to penetrate emerging biotech startups seeking experienced partners for clinical development and regulatory readiness.

Tech footprint Utilizes standard tech stack and data tools (iCIMS, WordPress, Redis, Microsoft 365, Piwik) that can be aligned with clients needing modern collaboration, data security, and analytics for clinical programs.

Revenue signals Revenue range ($10M–$25M) coupled with a lean employee base (2–10) indicates potential for scalable partnerships, white-labeling, or exclusive retainer arrangements to deliver flexible staffing and specialized QA and writing services.